Drug Approval | August 31, 2023
Lupin receives USFDA approval for Pirfenidone Capsules
Pirfenidone Capsules had estimated annual sales of USD 95 million in the US
Pirfenidone Capsules had estimated annual sales of USD 95 million in the US
This product will be manufactured at Lupin's Pithampur facility in India
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
The campaign seeks to raise awareness about hypertension while emphasising the significance of managing blood pressure for a healthier lifestyle
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
Bromfenac Ophthalmic Solution 0.09% (RLD Bromday) had estimated annual sales of USD 11 million in the U.S. (IQVIA MAT June 2023).
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
Jeet will be a trusted partner in cardiovascular care
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
Subscribe To Our Newsletter & Stay Updated
